Claudio Sampieri
Papers
10
Total Citations
134
H-Index
8
About
Claudio Sampieri is a leading surgical oncologist whose research centers on advancing transoral robotic surgery (TORS) for head and neck cancers, with a particular focus on laryngeal, hypopharyngeal, and oropharyngeal carcinomas. His major contributions include pioneering comparative studies of the da Vinci Single-Port versus multiport systems, demonstrating the SP system’s enhanced feasibility for complex hypopharyngeal and laryngeal procedures. Sampieri has also been instrumental in integrating neoadjuvant chemotherapy with TORS for stage III and IV cancers, showing this combined approach can reduce the need for adjuvant therapy—a significant step toward treatment de-escalation. His work on machine learning models to predict positive surgical margins, based on data from over 450 patients, represents a novel application of AI in robotic surgery. With papers accumulating 32, 22, and 15 citations, his research has shaped clinical protocols worldwide. Notably, his 2024 study on adjuvant radiation sparing after neoadjuvant chemotherapy and TORS in HPV-positive oropharyngeal cancer offers promising avenues for minimizing treatment toxicity. Sampieri’s innovative surgical techniques and predictive analytics continue to redefine precision in oncologic robotics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10